PLSH (Panacea Life Sciences Holdings) Change In Receivables: $-0.18 Mil (TTM As of Sep. 2025)


What is Panacea Life Sciences Holdings Change In Receivables?

Panacea Life Sciences Holdings PLSH Change In Receivables is $-0.18 Mil as of Sep. 2025. The stock has 10 warning signs investors should review.

Panacea Life Sciences Holdings's change in receivables for the quarter that ended in Sep. 2025 was $-0.15 Mil. It means Panacea Life Sciences Holdings's Accounts Receivable increased by $0.15 Mil from Jun. 2025 to Sep. 2025 .

Panacea Life Sciences Holdings's change in receivables for the fiscal year that ended in Dec. 2023 was $0.43 Mil. It means Panacea Life Sciences Holdings's Accounts Receivable declined by $0.43 Mil from Dec. 2022 to Dec. 2023 .

Panacea Life Sciences Holdings's Accounts Receivable for the quarter that ended in Sep. 2025 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Panacea Life Sciences Holdings's Days Sales Outstanding for the three months ended in Sep. 2025 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Panacea Life Sciences Holdings's liquidation value for the three months ended in Sep. 2025 was $1.61 Mil.

Panacea Life Sciences Holdings  (OTCPK:PLSH) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Panacea Life Sciences Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0.05*91
=0.00

2. In Ben Graham's calculation of liquidation value, Panacea Life Sciences Holdings's accounts receivable are only considered to be worth 75% of book value:

Panacea Life Sciences Holdings's liquidation value for the quarter that ended in Sep. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.008-0.234+0.75 * 0+0.5 * 3.678
=1.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings Change In Receivables Related Terms

Panacea Life Sciences Holdings Change In Receivables Historical Data

* Premium members only.

The historical data trend for Panacea Life Sciences Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings Change In Receivables Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Change In Receivables
0.15 -0.10 0.04 0.43

Panacea Life Sciences Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 0.31 -0.20 0.17 -0.15

Panacea Life Sciences Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-0.18 Mil mean?
Panacea Life Sciences Holdings (PLSH) has a Change In Receivables of $-0.18 Mil as of Sep. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Panacea Life Sciences Holdings and its competitors.
Is Panacea Life Sciences Holdings' Change In Receivables too high?
Panacea Life Sciences Holdings' current Change In Receivables is $-0.18 Mil.
How does Panacea Life Sciences Holdings' Change In Receivables compare to SKYI and IMCC?
Panacea Life Sciences Holdings' Change In Receivables of $-0.18 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Panacea Life Sciences Holdings and its competitors. Panacea Life Sciences Holdings's current Change In Receivables is $-0.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Change In Receivables of $-0.18 Mil. The current Change In Receivables is $-0.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Change In Receivables is $-0.18 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.